Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel protein, SRD5A3-RP11-177J6.1 readthrough (null)
- Target
- null
- Molecular classification
- Other (uncharacterized protein)
01
Overview
Novel protein, SRD5A3-RP11-177J6.1 readthrough" is an uncharacterized transcript combining SRD5A3 and RP11-177J6.1. Current evidence does not support its role as a drug target or its involvement in known disease mechanisms. Most relevant biological and therapeutic data relate to the SRD5A3 gene, which encodes steroid 5 alpha-reductase 3, an enzyme implicated in androgen metabolism, protein glycosylation, and cancer prognosis. The SRD5A3 protein is expressed in various cancer types, including breast cancer, and may act as a biomarker for disease progression and prognosis, but targeting the readthrough transcript itself is not supported by existing research[1][2][3][4].
- Other names
- ENSG00000288695AC064824.1SRD5A3-RP11-177J6.1 readthrough
02
Mechanism of action
Unknown (readthrough)
03
Biological functions
Unknown (for the readthrough)
04
Disease associations
Unknown (for the readthrough)
05
Safety considerations
Unknown for readthrough
06
Interacting drugs
None known for the readthrough
07
Biomarkers
None for the readthrough
Beyond the preview
Go deeper on Novel protein, SRD5A3-RP11-177J6.1 readthrough (null).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel protein, SRD5A3-RP11-177J6.1 readthrough (null).